139 related articles for article (PubMed ID: 31026603)
1. The interaction of human papillomaviruses and adeno-associated viruses in suppressive co-infections.
Hemmat N; Baghi HB
Infect Genet Evol; 2019 Sep; 73():66-70. PubMed ID: 31026603
[TBL] [Abstract][Full Text] [Related]
2. Temporal acceleration of the human papillomavirus life cycle by adeno-associated virus (AAV) type 2 superinfection in natural host tissue.
Agrawal N; Mane M; Chiriva-Internati M; Roman JJ; Hermonat PL
Virology; 2002 Jun; 297(2):203-10. PubMed ID: 12083819
[TBL] [Abstract][Full Text] [Related]
3. Altered biology of adeno-associated virus type 2 and human papillomavirus during dual infection of natural host tissue.
Meyers C; Alam S; Mane M; Hermonat PL
Virology; 2001 Aug; 287(1):30-9. PubMed ID: 11504539
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human papillomavirus type 16 and adeno-associated virus type 2 co-infecting human cervical epithelium.
Walz C; Deprez A; Dupressoir T; Dürst M; Rabreau M; Schlehofer JR
J Gen Virol; 1997 Jun; 78 ( Pt 6)():1441-52. PubMed ID: 9191942
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of adeno-associated virus and human papillomavirus DNA in Iranian women with and without cervical cancer.
Shafiei-Jandaghi NZ; Yavarian J; Faghihloo E; Ghavami N; Ghalejoogh ZY; Kiani SJ; Malekshahi SS; Shahsiah R; Jahanzad E; Hosseini M; Azad TM
Pathol Res Pract; 2017 May; 213(5):457-460. PubMed ID: 28285965
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus may play a protective role against human papillomavirus-induced cervical lesions independent of HIV serostatus.
Freitas LB; Tonani de Mattos A; Lima BM; Miranda AE; Spano LC
Int J STD AIDS; 2012 Apr; 23(4):258-61. PubMed ID: 22581949
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer.
Hermonat PL
Cancer Res; 1994 Apr; 54(8):2278-81. PubMed ID: 8174138
[TBL] [Abstract][Full Text] [Related]
8. Detection of adeno-associated virus DNA in female genital samples by PCR-ELISA.
Venturoli S; Cricca M; Bonvicini F; Gallinella G; Gentilomi G; Zerbini M; Musiani M
J Med Virol; 2001 Aug; 64(4):577-82. PubMed ID: 11468746
[TBL] [Abstract][Full Text] [Related]
9. Analysis of adeno-associated virus and HPV interaction.
Hermonat PL; You H; Chiriva-Internati CM; Liu Y
Methods Mol Med; 2005; 119():397-409. PubMed ID: 16350413
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus Rep78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16-ras chimeric.
Hermonat PL; Plott RT; Santin AD; Parham GP; Flick JT
Gynecol Oncol; 1997 Sep; 66(3):487-94. PubMed ID: 9299265
[TBL] [Abstract][Full Text] [Related]
11. The interaction between human papillomavirus and other viruses.
Guidry JT; Scott RS
Virus Res; 2017 Mar; 231():139-147. PubMed ID: 27826043
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus and human papillomavirus types in cervical samples of pregnant and non-pregnant women.
Freitas LB; Pereira CC; Checon R; Leite JP; Nascimento JP; Spano LC
Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):41-4. PubMed ID: 19410361
[TBL] [Abstract][Full Text] [Related]
13. Multiple human papillomavirus genes affect the adeno-associated virus life cycle.
You H; Liu Y; Prasad CK; Agrawal N; Zhang D; Bandyopadhyay S; Liu H; Kay HH; Mehta JL; Hermonat PL
Virology; 2006 Jan; 344(2):532-40. PubMed ID: 16203022
[TBL] [Abstract][Full Text] [Related]
14. Structural and cellular biology of adeno-associated virus attachment and entry.
Zengel J; Carette JE
Adv Virus Res; 2020; 106():39-84. PubMed ID: 32327148
[TBL] [Abstract][Full Text] [Related]
15. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
Hebner CM; Laimins LA
Rev Med Virol; 2006; 16(2):83-97. PubMed ID: 16287204
[TBL] [Abstract][Full Text] [Related]
16. High Prevalence of Infectious Adeno-associated Virus (AAV) in Human Peripheral Blood Mononuclear Cells Indicative of T Lymphocytes as Sites of AAV Persistence.
Hüser D; Khalid D; Lutter T; Hammer EM; Weger S; Heßler M; Kalus U; Tauchmann Y; Hensel-Wiegel K; Lassner D; Heilbronn R
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928011
[TBL] [Abstract][Full Text] [Related]
17. Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.
Biryukov J; Meyers C
J Virol; 2018 Apr; 92(8):. PubMed ID: 29437958
[TBL] [Abstract][Full Text] [Related]
18. Inhibition/stimulation of bovine papillomavirus by adeno-associated virus is time as well as multiplicity dependent.
Hermonat PL; Meyers C; Parham GP; Santin AD
Virology; 1998 Aug; 247(2):240-50. PubMed ID: 9705917
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic human papillomaviruses.
McBride AA
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893940
[TBL] [Abstract][Full Text] [Related]
20. Suppression of tumorigenicity in cervical carcinoma HeLa cells by an episomal form of adeno-associated virus.
Wu FY; Wu CY; Lin CH; Wu CH
Int J Oncol; 1999 Jul; 15(1):101-6. PubMed ID: 10375600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
